TINA NORTON: Open Payments
NPI 1831435726 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 33 payments from 12 companies in 2025. Trend: 2023 $1,082 · 2024 $1,635 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $134 |
| Alkermes, Inc. | 6 | $103 |
| Janssen Pharmaceuticals, Inc | 5 | $101 |
| ABBVIE INC. | 4 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Supernus Pharmaceuticals, Inc. | 3 | $43 |
| Lundbeck LLC | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: INVEGA SUSTENNA, UZEDY, ARISTADA, VRAYLAR, REXULTI, Qelbree, HETLIOZ, AUSTEDO XR.
Industry payments across KS — which companies pay providers there.
